Anti-angiogenics
From Self-sufficiency
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2006) |
Anti-angiogenics is a class of drug that prevents the formation of abnormal, new blood vessels in the eye, and dries up vessels which have already begun to leak.
One anti-angiogenic drug is Lucentis (ranibizumab), which is used to treat wet age-related macular degeneration (wet AMD). Injections of Lucentis can improve sight in people with a particular form of retinal degeneration.
See also
- Angiogenesis
- Royal National Institute of the Blind
- Royal College of Ophthalmologists
- Macular Disease Society
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
